Literature DB >> 25796985

Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.

Lin Sun1, Chang He1, Lekha Nair1, Justine Yeung1, Charles E Egwuagu2.   

Abstract

Cytokines play crucial roles in coordinating the activities of innate and adaptive immune systems. In response to pathogen recognition, innate immune cells secrete cytokines that inform the adaptive immune system about the nature of the pathogen and instruct naïve T cells to differentiate into the appropriate T cell subtypes required to clear the infection. These include Interleukins, Interferons and other immune-regulatory cytokines that exhibit remarkable functional redundancy and pleiotropic effects. The focus of this review, however, is on the enigmatic Interleukin 12 (IL-12) family of cytokines. This family of cytokines plays crucial roles in shaping immune responses during antigen presentation and influence cell-fate decisions of differentiating naïve T cells. They also play essential roles in regulating functions of a variety of effector cells, making IL-12 family cytokines important therapeutic targets or agents in a number of inflammatory diseases, such as the CNS autoimmune diseases, uveitis and multiple sclerosis. Published by Elsevier Ltd.

Entities:  

Keywords:  Adoptive B cell therapy; Autoimmune disease; Cytokine therapy; IL-12 family cytokines; Regulatory B cells (Bregs and i35-Bregs)

Mesh:

Substances:

Year:  2015        PMID: 25796985      PMCID: PMC4553122          DOI: 10.1016/j.cyto.2015.01.030

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  69 in total

1.  Expression of murine IL-12 is regulated by translational control of the p35 subunit.

Authors:  J M Babik; E Adams; Y Tone; P J Fairchild; M Tone; H Waldmann
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

2.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

Authors:  Jin-Qing Liu; Zhenzhen Liu; Xuejun Zhang; Yun Shi; Fatemeh Talebian; Joseph W Carl; Chuan Yu; Fu-Dong Shi; Caroline C Whitacre; Joanne Trgovcich; Xue-Feng Bai
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

4.  Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis.

Authors:  Daewoong Jo; Danya Liu; Shan Yao; Robert D Collins; Jacek Hawiger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440

5.  Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.

Authors:  Lilian W Waiboci; Chulbul M Ahmed; Mustafa G Mujtaba; Lawrence O Flowers; James P Martin; Mohammed I Haider; Howard M Johnson
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

6.  Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Meifen Zhang; Rashid M Mahdi; Stephen J Kim; Igal Gery
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 7.  Possible roles of IL-12-family cytokines in rheumatoid arthritis.

Authors:  Richard M Pope; Shiva Shahrara
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

8.  Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Authors:  Timothy J Harris; Joseph F Grosso; Hung-Rong Yen; Hong Xin; Marcin Kortylewski; Emilia Albesiano; Edward L Hipkiss; Derese Getnet; Monica V Goldberg; Charles H Maris; Franck Housseau; Hua Yu; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.

Authors:  Burkhard Becher; Brigit G Durell; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors:  Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

View more
  64 in total

Review 1.  Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Lin Sun; Renxi Wang
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-20       Impact factor: 7.638

2.  Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice.

Authors:  X Wang; X Liu; Y Zhang; Z Wang; G Zhu; G Han; G Chen; C Hou; T Wang; N Ma; B Shen; Y Li; H Xiao; R Wang
Journal:  Clin Exp Immunol       Date:  2016-08-12       Impact factor: 4.330

Review 3.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

Review 4.  Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.

Authors:  Christian Fercher; Sahar Keshvari; Michael A McGuckin; Ross T Barnard
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-19

Review 5.  Cytokine-mediated communication: a quantitative appraisal of immune complexity.

Authors:  Grégoire Altan-Bonnet; Ratnadeep Mukherjee
Journal:  Nat Rev Immunol       Date:  2019-04       Impact factor: 53.106

Review 6.  Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

7.  The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum.

Authors:  Li-Xin Sun; Zhi-Bin Lin; Jie Lu; Wei-Dong Li; Yan-Dong Niu; Yu Sun; Chen-Yang Hu; Guo-Qiang Zhang; Xin-Suo Duan
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 8.  Rs-10889677 variant in interleukin-23 receptor may contribute to creating an inflammatory milieu more susceptible to bladder tumourigenesis: report and meta-analysis.

Authors:  Mohammed El-Gedamy; Zakaria El-Khayat; Hassan Abol-Enein; Afaf El-Said; Eslam El-Nahrery
Journal:  Immunogenetics       Date:  2021-03-04       Impact factor: 2.846

9.  Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis.

Authors:  Uğur Kulu; Bedile İrem Tiftikcioğlu; Yaşar Zorlu; Mustafa Çetiner; Ufuk Şener; Gamze Tuna; Güldal Kirkali
Journal:  Noro Psikiyatr Ars       Date:  2016-03-28       Impact factor: 1.339

Review 10.  Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines.

Authors:  Kaveh Abdi; Nevil J Singh
Journal:  Cytokine       Date:  2015-08-01       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.